Document is current
Any future updates will be listed below
-
Authors
Morishita, Toshimasa
Nishizaki, Naoto
Taniguchi, Sakiko
Sakai, Shinsuke
Kimura, Tomonori
Mita, Masashi
Nakagawa, Mayu
Endo, Amane
Ohtomo, Yoshiyuki
Yasui, Masato
Shimizu, Toshiaki
Sasabe, Jumpei
-
Funding
Funding for this research was provided by:
Keio University (Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research)
- License Information
-
More Information
Article History
Received: 6 February 2024
Accepted: 29 May 2024
First Online: 6 June 2024
Declarations
:
: This study was approved by the institutional Ethics Committee and conducted in accordance with the Helsinki Declaration and institutional guidelines for clinical studies as Juntendo University Hospital (Approval number: 22–031). We obtained conset from parents of 27 individuals, who visited the pediatric nephrology outpatient clinics of Juntendo University Hospital, Juntendo University Nerima Hospital, Juntendo University Urayasu Hospital, and Juntendo University Shizuoka Hospital between July 2022 and April 2023.
: Not applicable.
: Not applicable.
: The authors have no relevant financial interests to disclose. M.M. is a founder and CEO of KAGAMI INC., a company working on analysis of chiral amino acids.
